Reklāma
Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares
(RTTNews) - Biotechnology company Horizon Therapeutics plc (HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares.
Under the program, the Company may repurchase ordinary shares from time to time on the open market or through privately negotiated transactions or structured repurchase transactions.
As of June 30, 2022, the Company had cash and cash equivalents of $1.89 billion. The Company expects to fund the repurchase of its ordinary shares under the program with existing cash and cash equivalents.
read more
Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4
Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.
RTTNews
|
804 days ago
Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD
Biotechnology company Horizon Therapeutics plc (HZNP) announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.
RTTNews
|
1059 days ago
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab
Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).
RTTNews
|
1086 days ago
Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint
Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.
RTTNews
|
1158 days ago
Asian Markets Track Wall Street Lower
Asian stock markets are trading mostly lower on Friday, following the broadly negative cues from Wall Street overnight, reflecting uncertainty whether key U.S. economic reports will be released following the end of the longest government shutdown in U.S. history, which could alter the US Fed's decision on interest rates. Asian markets ended mostly higher on Thursday.
RTTNews
|
1h 14min ago
Indian Shares Set For Muted Opening; Bihar Election Results Eyed
Indian shares are set for a muted opening on Friday as investors await the Bihar election results for directional cues.
RTTNews
|
1h 33min ago
China Industrial Output Gains An Annual 4.9% In October
Industrial production in China was up 4.9 percent on year in October, the National Bureau of Statistics said on Friday.
RTTNews
|
1h 58min ago
Thai Stock Market May Turn Lower Again On Friday
The Thai stock market on Thursday snapped the two-day slide in which it had given up more than 20 points or 1.6 percent. The Stock Exchange of Thailand now sits just above the 1,285-point plateau although it may hand back those gains on Friday.
RTTNews
|
2h 13min ago
